Psoriasis und Schwangerschaft. Klinischer Algorithmus und Monitoring bei Systemtherapie

Standard

Psoriasis und Schwangerschaft. Klinischer Algorithmus und Monitoring bei Systemtherapie. / Stephan, B; Augustin, M.

In: HAUTARZT, Vol. 71, No. 8, 08.2020, p. 607-612.

Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

Harvard

APA

Vancouver

Bibtex

@article{a8a4d3c496e24cefbcadd4e6d6f2b7c3,
title = "Psoriasis und Schwangerschaft. Klinischer Algorithmus und Monitoring bei Systemtherapie",
abstract = "The recently expanded approval of some TNF‑α blockers for the treatment of moderate to severe psoriasis in pregnancy has facilitated therapy of this group of patients with approved drugs. To date, there are no evidence-based structured therapy recommendations for these psoriasis patients with the result that the uncertainties of the treating physicians usually lead to individual decisions. On the basis of our clinical experience and the currently valid approval for systemic therapeutics, we have developed a therapy algorithm that enables an interdisciplinary, structured approach to counseling and supporting pregnant women with psoriasis, which makes decision-making for colleagues in other disciplines, in particular gynecology, transparent.",
keywords = "Algorithms, Female, Humans, Immunologic Factors/therapeutic use, Immunosuppressive Agents/therapeutic use, Pregnancy, Pregnancy Complications/drug therapy, Psoriasis/diagnosis",
author = "B Stephan and M Augustin",
year = "2020",
month = aug,
doi = "10.1007/s00105-020-04607-1",
language = "Deutsch",
volume = "71",
pages = "607--612",
journal = "HAUTARZT",
issn = "0017-8470",
publisher = "Springer",
number = "8",

}

RIS

TY - JOUR

T1 - Psoriasis und Schwangerschaft. Klinischer Algorithmus und Monitoring bei Systemtherapie

AU - Stephan, B

AU - Augustin, M

PY - 2020/8

Y1 - 2020/8

N2 - The recently expanded approval of some TNF‑α blockers for the treatment of moderate to severe psoriasis in pregnancy has facilitated therapy of this group of patients with approved drugs. To date, there are no evidence-based structured therapy recommendations for these psoriasis patients with the result that the uncertainties of the treating physicians usually lead to individual decisions. On the basis of our clinical experience and the currently valid approval for systemic therapeutics, we have developed a therapy algorithm that enables an interdisciplinary, structured approach to counseling and supporting pregnant women with psoriasis, which makes decision-making for colleagues in other disciplines, in particular gynecology, transparent.

AB - The recently expanded approval of some TNF‑α blockers for the treatment of moderate to severe psoriasis in pregnancy has facilitated therapy of this group of patients with approved drugs. To date, there are no evidence-based structured therapy recommendations for these psoriasis patients with the result that the uncertainties of the treating physicians usually lead to individual decisions. On the basis of our clinical experience and the currently valid approval for systemic therapeutics, we have developed a therapy algorithm that enables an interdisciplinary, structured approach to counseling and supporting pregnant women with psoriasis, which makes decision-making for colleagues in other disciplines, in particular gynecology, transparent.

KW - Algorithms

KW - Female

KW - Humans

KW - Immunologic Factors/therapeutic use

KW - Immunosuppressive Agents/therapeutic use

KW - Pregnancy

KW - Pregnancy Complications/drug therapy

KW - Psoriasis/diagnosis

U2 - 10.1007/s00105-020-04607-1

DO - 10.1007/s00105-020-04607-1

M3 - SCORING: Zeitschriftenaufsatz

C2 - 32458008

VL - 71

SP - 607

EP - 612

JO - HAUTARZT

JF - HAUTARZT

SN - 0017-8470

IS - 8

ER -